The unique mode of action differentiates Triomab®-compounds clearly from all other antibody-based therapies. Required doses are up to 10,000 fold lower than those needed of conventional antibodies. Moreover, chronic treatment may become obsolete.

undefinedSee relevant publications

The resulting tri-cell-complex triggers multiple immune mechanisms at the same time.  Not only are tumor cells specifically and potently destroyed, but a long-lasting anti-tumor immunity is also induced – an effect that can otherwise only be achieved through vaccination.

Mode of action